Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0221002 (
primary hyperparathyroidism
)
4,921
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Bone Mass Measurement Act (BMMA) set forth regulations to provide for uniform coverage under Medicare Part B for bone mass measurements for services provided on or after July 1, 1998. The BMMA authorizes Medicare coverage of "medically necessary approved measurements" performed for a "qualified individual" who falls into at least one of five diagnostic categories: an estrogen-deficient woman at clinical risk for osteoporosis; an individual with vertebral abnormalities; an individual receiving long-term glucocorticoid (steroid) therapy; an individual with
primary hyperparathyroidism
; and an individual being monitored to assess the response to, or efficacy of, an approved osteoporosis drug therapy. Proper communication is essential for reimbursement. The tools for communication include Physician's Current Procedural Terminology (CPT), HCFA (Health Care Financing Administration) Common Procedure Coding System (HCPCS), the Medicare carrier's local Medical Review Policy (LMRP), and the International Classification of Diseases, ninth revision (
ICD
-9). This article reviews the new regulations and the tools for communication.
...
PMID:Understanding the Bone Mass Measurement Act. 1054 16
A case of a patient with an automatic cardioverter defibrillator (
ICD
) and recurrent ventricular arrhythmic storms related to
primary hyperparathyroidism
and hypercalcaemia is reported: medical therapy was ineffective and only surgical resection of the parathyroid adenoma resolved this complex clinical condition.
...
PMID:Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death. 1512 Oct 67
External ionizing radiation is a risk factor for
primary hyperparathyroidism
. Whether exposure to radioactive iodine contributes to the risk of
primary hyperparathyroidism
is unknown. Patients with thyrotoxicosis are often treated with radioactive iodine and its accumulation in the thyroid gland exposes the adjacent parathyroid glands to radioactivity. Six thousand and eighty two patients with thyrotoxicosis (
ICD
-9 = 242) were identified from medical records. In a randomly selected subcohort we assessed the frequency of treatment with radioactive iodine to be 86%. The number of patient-years at risk was 77,118. Patients with parathyroid adenomas (
ICD
-9 = 195.1) were recruited from the Swedish Cancer Registry. Eleven patients with parathyroid adenomas following the diagnosis of thyrotoxicosis were identified. The standard incidence ratio (SIR) compared to the reference population of approximately 900,000 was 1.14 (95% CI 0.57-2.03). The median age at exposure was 59 years and the latency period between diagnosis of thyrotoxicosis and parathyroid adenoma was 7.4 years (range <1-19 years). This study does not indicate that patients with thyrotoxicosis treated with radioactive iodine in adult age have increased risk of developing parathyroid adenoma.
...
PMID:Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine. 1711 39
Chronic somatic pain disorders with somatic and mental factors (
ICD
-10: F45.41) are common among psychosomatic patients. In the present case, due to the close temporal association with a trauma and the subsequent development of symptoms including depressive symptoms, a chronic pain disorder with a relevant somatoform component was suspected. However, after a period of several months without significant somatic findings, targeted diagnostic approaches resulted in the diagnoses of
primary hyperparathyroidism
and a papillary thyroid carcinoma. Surgical therapy resulted in an almost complete decline of symptoms within a short period of time.
...
PMID:[Chronic musculoskeletal pain syndrome in primary hyperparathyroidism]. 2236 36
Hypercalcemia is a known cause of heart rhythm disorders, however its association with ventricular arrhythmias is rare. The authors present a case of a fifty-three years old male patient with a ischemic and ethanolic dilated cardiomyopathy, and severely reduced ejection fraction, carrier of cardiac resynchronization therapy (CRT) with cardioverter defibrillator (
ICD
), admitted in the emergency department with an electrical storm, with multiple appropriated
ICD
shocks, refractory to antiarrhythmic therapy. In the etiological investigation was documented severe hypercalcemia secondary to
primary hyperparathyroidism
undiagnosed until then. Only after the serum calcium level reduction ventricular tachycardia was stopped.
...
PMID:Hypercalcemic crisis and primary hyperparathyroidism: Cause of an unusual electrical storm. 2922 81